Search the Newsreel

Red Violet Inc (RDVT) Stock Down 4.4% but Still Overvalued -- GF Score: 68/100

Red Violet Inc (RDVT) shares dropped 4.4% to $63.13, yet the stock remains significantly overvalued, trading 50.7% above its GF Value™ of $41.90. Despite a solid GF Score™ of 68/100, driven by strong financial strength and momentum, its valuation score is low (3/10). Further, …

Wednesday 7/22 Insider Buying Report: NMM, CHCO

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Navios Maritime Partners, a filing with …

Artivion (AORT) Grew in Q1, but AMDS Timing and Lower 2026 Targets Still Softened the Story

Artivion (AORT) reported strong Q1 2026 financial results with significant revenue and adjusted EBITDA growth. However, the company lowered its full-year 2026 guidance due to "transient factors" and slower-than-expected AMDS product timing, concerning investors. While other product categories showed robust growth, the revised outlook …

Enterprise value to EBIT forward of Navios Maritime Partners LP – GETTEX:3PXA

The article focuses on the "Enterprise value to EBIT forward" metric for Navios Maritime Partners LP, traded on GETTEX under the symbol 3PXA. It appears to be a financial data page from TradingView, offering an overview of the company's financial performance. The content is …

Price to earnings forward of Navios Maritime Partners LP – NYSE:NMM

This article provides a brief financial overview of Navios Maritime Partners LP (NYSE: NMM), specifically focusing on its forward price-to-earnings ratio. It presents a single data point for this metric and indicates that the information is provided by FactSet. The content is sparse, serving …

Citizens reiterates Artivion stock rating citing FDA approval benefits

Citizens has reiterated a Market Outperform rating and a $48.00 price target for Artivion Inc. (NYSE:AORT), citing benefits from recent FDA approval of its AMDS Hybrid Prosthesis platform. Despite a year-to-date stock decline, the company expects momentum to build in late 2026 and 2027 …

Covivio Hotels (ENXTPA:COVH) Looks Fully Valued On Southern Europe Expansion Push

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. How Covivio Hotels' Southern Europe push shapes the stock story Covivio Hotels (ENXTPA:COVH) recently outlined plans to expand further in Southern Europe and continue …

Viomi Gets 180 Days to Regain Compliance With Nasdaq's $1 Rule

Viomi (NASDAQ: VIOT) announced it received a notice from Nasdaq on July 22, 2026, indicating non-compliance with the US$1.00 minimum bid price rule after its ADSs traded below this level for 30 consecutive business days. The company has a 180-day grace period, until January …

Artivion (AORT) Cuts Guidance Following AMDS Slower Adoption, Is It Still Below Fair Value?

Artivion (AORT) recently cut its full-year guidance due to slower-than-expected adoption of its AMDS product, despite reporting 12% non-GAAP constant currency revenue growth in Q1 2026. This has led to a significant share price drop, though a popular narrative values the stock at $42, …

Navios Maritime Partners: Still Hasn't Earned My Trust Despite The Rally (NYSE:NMM)

Les prévisions sur Covivio restent inchangées et inférieures au consensus, le titre est en repli de -1%

Indivior stock trades steady as opioid treatment specialist rebuilds after 2024 setback

Indivior PLC is rebuilding investor confidence after a challenging 2024 marked by significant litigation costs that led to a net loss of $140 million, despite stable revenue and improved adjusted operating profit. The company is focusing on strengthening its balance sheet through debt reduction …

FOREWARN Expands into Home Healthcare, Bringing Real-Time Safety Intelligence to Caregivers Nationwide

FOREWARN, a red violet company, has expanded its data-driven safety solutions into the home healthcare industry with "FOREWARN for Home Healthcare." This new offering provides caregivers and agencies with pre-visit household insights to enhance safety and manage risks in unpredictable environments. The solution aims …

Avoiding Lag: Real-Time Signals in (RDVT) Movement

The article provides a real-time analysis of Red Violet Inc. (NASDAQ: RDVT) stock movements, highlighting conflicting sentiment across different time horizons, which suggests choppy trading conditions. It details several AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The …

Red Violet (RDVT) Enhances Home Healthcare Safety Solutions

Red Violet Inc. (RDVT), through its subsidiary Forewarn, has expanded its data-driven safety services to the home healthcare sector, aiming to enhance caregiver safety by providing pre-visit insights into households. While the company demonstrates strong financial health and a commitment to innovation, its high …

Bain Capital acquires SupplyOn

Bain Capital, a private investment firm, has announced that it has agreed to acquire SupplyOn, a supply chain collaboration platform serving the automotive, aerospace and defence, and other advanced manufacturing sectors across Europe. It has acquired the firm from its shareholders Aumovio, Bosch, Schaeffler …

Home Caregivers Get Pre-Visit Safety Insights Before Entering Homes

Red Violet, through its subsidiary FOREWARN, has expanded its real-time, data-driven safety intelligence platform into the home healthcare industry with "FOREWARN for Home Healthcare." This new solution provides pre-visit insights, identity verification, and information on potential criminal history for household occupants to enhance caregiver …

Needham reiterates Artivion stock rating on product cycle outlook

Needham has reiterated a Buy rating and a $44.00 price target for Artivion Inc. (NYSE:AORT), citing a significant product cycle driven by its AMDS and upcoming NEXUS products. The firm expects these products to boost revenue growth and adjusted EBITDA, anticipating a reacceleration of …

Form 4 Navios Maritime Partners L.P. For: 20 July By Investing.com

This article reports on the filing of Form 4 for Navios Maritime Partners L.P. on July 20. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders to report changes in their beneficial ownership …

(NMM) Price Dynamics and Execution-Aware Positioning

This article provides an AI-generated analysis of Navios Maritime Partners Lp (NYSE: NMM), highlighting a weak near-term sentiment but strong mid and long-term outlook. It details specific institutional trading strategies, including position trading, momentum breakout, and risk hedging, with defined entry zones, targets, and …

Indivior stock holds a recovery path as opioid treatment demand supports revenue

Indivior PLC's stock is showing signs of recovery, driven by strong demand for its opioid use disorder treatments and its ability to manage past legal settlements. The company's revenue growth, profitability metrics, and market capitalization are key indicators investors use to evaluate its balance …

Indivior stock trades steadily as recent earnings and guidance frame addiction-treatment strategy

Indivior stock is trading steadily despite ongoing scrutiny, reflecting strong earnings, improved margins, and reduced legal provisions. The company, focused on addiction treatment, reported annual revenue above $1 billion in fiscal 2025 and improved operating cash flow. Investors are closely watching prescription volumes for …

Indivior stock trades steady as revenue grows and opioid treatment portfolio expands

Indivior PLC, a specialty pharmaceutical company focused on opioid use disorder and addiction treatments, shows steady stock performance driven by growing revenues and resilient margins. The company's financial health is supported by its buprenorphine-based products, diversification into extended-release injectable formulations, and disciplined cost management, …

Navios Maritime Partners (NMM) CEO adds common units under Rule 10b5-1 plan

Angeliki Frangou, CEO and Chairwoman of Navios Maritime Partners L.P. (NMM), indirectly purchased 3,348 common units between July 15-17, 2026, through an affiliated entity, Raymar Investments S.A., under a Rule 10b5-1 trading plan. The purchases were made at weighted average prices ranging from $72.6181 …

Navios Maritime Partners CEO, Chairwoman Angeliki Frangou reports USD 249,773 common unit purchase

Angeliki Frangou, Chairwoman and CEO of Navios Maritime Partners, purchased 3,348 common units totaling $249,773 at weighted average prices between $72.62 and $75.13. This transaction increased her indirect beneficial ownership to 4,772,131 common units, in addition to Olympos Maritime's 622,296 general partnership units. The …

Indivior stock trades steady as opioid treatment specialist focuses on growth after recent earnings

Indivior's stock performance is influenced by the balance between its growing opioid use disorder treatment sales and ongoing legal settlement costs. The company's recent earnings show strong revenue growth driven by its flagship opioid use disorder therapies, with profitability metrics indicating underlying operational strength …

Indivior stock holds steady as addiction-treatment strategy stays in focus

Indivior stock reflects the company's focus on addiction therapies, particularly opioid use disorder, positioning it within long-term healthcare trends. The company's strategy involves expanding treatment options, operating within a heavily regulated environment, and facing competition in a specialized niche. Its long-term approach includes R&D …

Artivion (AORT) Corporate presentation Summary

Artivion (AORT) presented a summary of its financial performance, growth strategies, and product innovation, highlighting its specialization in aortic disease. The company reported FY25 revenue of $444 million and projected FY26 revenue of $480–496 million, with strong EBITDA growth and reduced net debt. Key …

Navios Maritime Partners (NMM) Registration filing Summary

This article summarizes Navios Maritime Partners' (NMM) registration filing, detailing its business model as an international owner and operator of dry cargo and tanker vessels. It highlights the company's diversified fleet, financial performance as of March 2026, and its intended use of proceeds for …

Avio Smart Market Stack Ltd Q4 Results 2026 - Find Avio Smart Market Stack Ltd Q4 Earnings Result | ASMS Q4 results

Navios Maritime Partners (NYSE: NMM) insider adds 3,334 units under 10b5-1 plan

Angeliki Frangou, a director, officer, and 10% owner of Navios Maritime Partners L.P. (NYSE: NMM), purchased 3,334 common units through an affiliated entity, Raymar Investments S.A., between July 10 and July 14, 2026. These transactions, executed under a Rule 10b5-1 trading plan, occurred at …

AMV0 Prognose — Kursziel für 2027

Avio Smart Market Stack appoints Sandeep Pandya to lead global sales

How Investors Are Reacting To Indivior (INDV) Upgraded 2026 Outlook And $175 Million Buyback Plan

INDV Stock: What Sublocade Growth Signals for 2026

Avio Smart Market Stack explores diagnostics collaboration with Medici Institute